AQP4 and relapsing-remitting multiple sclerosis: Subsequently, we explored the pathogenetic characteristics of ITM, comparing sNfL and sGFAP levels between patients with ITM and those with other CIDDs—relapsing–remitting MS (RRMS) and AQP4 + NMOSD—during acute attack and remission phases.